The global respiratory filters market size was estimated at USD 532.3 billion in 2022 and is estimated to grow at a compound annual growth rate (CAGR) of 5.5% from 2023 to 2030. The increasing prevalence of respiratory diseases, such as asthma, COPD, etc., and the rising global geriatric population are major factors driving the market’s growth. Elderly people often experience compromised lung function and are more susceptible to respiratory infections. This drives the demand for respiratory care, including ventilators and oxygen therapy. These filters are critical in preventing inhaling airborne contaminants and pathogens, reducing the risk of respiratory infections and complications among the elderly. Moreover, the market growth is driven by the growing launch of new-generation products, which are anticipated to create potential growth opportunities. Companies operating in the market have undertaken various strategic initiatives.
The growing prevalence of respiratory diseases is one of the key factors propelling the market growth. According to the WHO, 3.23 million people died due to COPD, the third-largest cause of death worldwide in 2019. Likewise, the WHO also estimates that by 2030, the four primary potentially fatal respiratory diseases—lung cancer, tuberculosis, COPD, & pneumonia—will cause approximately one in five deaths globally, up from one-sixth of all deaths in the world in 2008. The increasing need for emergency treatment for prolonged illnesses and protracted treatment associated with lung diseases in children and adults is expected to drive the market growth. According to statistics published by the American College of Allergy, Asthma & Immunology, approximately 8.3% of Americans have asthma.
In addition, factors, such as lack of physical activity, obesity, overconsumption of tobacco & alcohol, and unhealthy eating habits, are likely to increase the incidence of respiratory disorders, which would contribute to market growth over the forecast period. The global use of respiratory filters is anticipated to substantially increase due to the rising geriatric population over the forecast period. According to a Population Reference Bureau report—Aging in the United States—the geriatric population in the U.S. is estimated to increase from 52 million in 2018 to 95 million by 2060. Similarly, according to a report by the United Nations, the global population of individuals aged 60 years and above is projected to rise significantly, from 962 million in 2017 to 2.1 billion by 2050 and 3.1 billion by 2100.
Elderly people are more susceptible to respiratory diseases like COPD and sleep apnea. Furthermore, the growing geriatric population in Asian countries is also increasing the market potential and is expected to drive growth over the forecast period. Therefore, the increasing geriatric population is expected to increase the patient pool and drive market growth. In addition, the growing initiatives by government and private organizations, such as the COPD Foundation, that encourage awareness regarding respiratory illnesses & available treatments, are creating significant potential opportunities in the market. Omron Healthcare India and Lupin Ltd. established a long-term strategic partnership in June 2020 to improve respiratory disease treatment programs in India, primarily focusing on patients with asthma and COPD.
This collaboration will usher in a new era of improving drug delivery, adherence, diagnosis, and awareness. In September 2022, Alkem Labs launched a new campaign to raise lung health awareness. With the help of its program, “The Healthy Lungs”, the company has promised to raise awareness. Patients can access the patient community through the Healthy Lungs portal (www.thehealthylungs.com), which serves as a platform for experience sharing. Through this program, patients can access virtual educators, physical camps, and doctor presentations to learn about diseases and effective inhaler techniques. Moreover, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) launched in 1997 in collaboration with the National Heart, Lung, and Blood Institute; WHO; & National Institutes of Health works with healthcare specialists and public health administrators around the globe to raise awareness about COPD and improve its prevention & treatment.
Every year, GOLD chooses a theme for World COPD Day and coordinates the preparation & distribution of information as well as resources. Healthcare workers, educators, and members of the public who want to make an impact locally and globally arrange World COPD Day activities in their country. Organizers in over 50 countries hold activities annually, making COPD Day one of the world's most significant awareness & education events. Hence, the growth of such supportive initiatives is expected to drive market growth. Furthermore, several campaigns and programs have been launched by many governments, nongovernment organizations, and market players to educate citizens about respiratory health and ways to manage it. For instance, Royal Philips India announced a new campaign in May 2019 to increase awareness about asthma and related respiratory diseases, particularly in children.
The positive airway pressure device filters segment led the market and accounted for the largest revenue share of 23.9% in 2022. The growing patient pool suffering from obstructive sleep apnea is expected to drive the demand for PAP devices. Consequently, PAP device filter market growth. In addition, the presence of renowned players and favorable support from government bodies and insurance firms have also supported market growth. For instance, Medicare and other private insurance organizations in the U.S. reimburse approximately 80% of the costs incurred by patients while purchasing PAP machines and accessories, thereby promoting the adoption of sleep apnea treatment solutions.
The humidifier filters segment is expected to witness the fastest CAGR of 6.8% over the forecast period. An increase in demand for humidifiers in hospitals, schools, homes, and healthcare entities is expected to boost the humidifier filter segment growth, as filters are needed to prevent the growth of molds, mildew, fungi, and bacteria in the circulating air. Moreover, an increase in the prevalence of airborne infections, such as tuberculosis, drives the demand for filters in humidifiers, thus boosting segment growth. Using a humidifier makes the air more humid and protects against environmental dryness. Customers' increasing knowledge of conditions like asthma, sinusitis, and certain allergies is anticipated to increase demand for humidifier equipment. As a result, it drives the market growth.
The hospitals segment dominated the market and held the largest revenue share of 34.1% in 2022. The segment is expected to continue its dominance with the fastest growth rate of 5.8% over the forecast period. Hospitals are the primary centers for diagnosing and treating various respiratory conditions and diseases, including acute respiratory infections and chronic obstructive pulmonary disease (COPD). The increasing prevalence of these respiratory ailments has led to a higher demand for respiratory care and interventions, thereby driving the need for effective respiratory filters. In addition, hospitals handle a diverse range of patients, including those with compromised immune systems and respiratory vulnerabilities.
As healthcare facilities must maintain high hygiene standards and prevent cross-contamination, using advanced respiratory filters becomes essential. These filters help minimize the spread of airborne pathogens, allergens, and pollutants, ensuring a safe environment for patients and healthcare professionals. Moreover, the ongoing efforts to manage and prevent respiratory infections, especially after global health crises like COVID-19, have spurred hospitals to enhance their respiratory protection measures. This includes the widespread adoption of respiratory filters in various medical devices, such as ventilators and anesthesia machines, to ensure optimal patient care and infection control.
North America dominated the global market and held the largest revenue share of 37.2% in 2022. The market growth in this region can be attributed to the availability of the latest technologies and product launches. Some of the market leaders in North America are GE Healthcare, CAIRE, Inc., Koninklijke Philips N.V., and Medtronic. Furthermore, the increasing prevalence of respiratory disorders is expected to boost the market growth. For instance, according to the CDC, the incidence of Tuberculosis (TB) (cases per 100,000 population) among Americans increased from 0.71 in 2020 to 0.79 in 2021, while it grew from 11.71 in 2020 to 12.16 in 2021 among non-Americans. The growing number of patients with TB further boosts the demand for respiratory care devices involved in TB therapy, which, in turn, is boosting the demand for respiratory care devices, such as respiratory filters, thereby driving the market growth.
Asia Pacific is expected to witness the fastest CAGR of 6.2% over the forecast period. The region’s high prevalence of respiratory diseases, increasing applications in home care settings, continuation of demographic & economic trends, and technological advancements are major factors contributing to the regional market growth. Furthermore, some major market players are adopting certain strategic initiatives, such as collaborations, acquisitions, and new product launches, to strengthen their market position. For instance, in April 2020, CAIRE, Inc. expanded its oxygen therapy solutions portfolio in China. With this, the company will be able to expand the distribution of its oxygen therapy solutions in the country. Thus, the growing focus on developing innovative respiratory devices will drive the regional market growth over the forecast period.
Key companies are actively formulating strategic approaches to enhance their market presence and gain a competitive advantage within the sector. These key players are emphasizing strategic maneuvers, encompassing M&As, collaborative ventures, partnerships, substantial investments, and the introduction of innovative products to augment their capabilities and broaden their range of offerings. For instance, in April 2022, CAIRE, Inc. expanded its oxygen portfolio with Companion 5 and new life intensity 10 stationary oxygen concentrators in Brazil. Due to the COVID-19 pandemic, there was a shortage of oxygen across Latin America, which created an opportunity for the company to expand its oxygen therapy portfolio. This positively impacted the market growth, aligning with the broader objective of ensuring patient safety and well-being. Some of the major players in the global respiratory filters market are:
GE Healthcare
Koninklijke Philips N.V.
ICU Medical (Smiths Medical)
Invacare Corporation
Medtronic
Fisher & Paykel Healthcare
ResMed
Linde
Mindray
Chart Industries
Drägerwerk AG & Co. KGaA
DeVilbiss Healthcare
Report Attribute |
Details |
Market size value in 2023 |
USD 549.9 million |
Revenue forecast in 2030 |
USD 802.4 million |
Growth rate |
CAGR of 5.5% from 2023 to 2030 |
Base year for estimation |
2022 |
Historical data |
2018 - 2021 |
Forecast period |
2023 - 2030 |
Quantitative units |
Revenue in USD million and CAGR from 2023 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; Germany; UK; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; Australia; South Korea; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
Key companies profiled |
GE Healthcare; Koninklijke Philips N.V.; ICU Medical (Smiths Medical); Invacare Corporation; Medtronic; Fisher & Paykel Healthcare; ResMed; Linde; Mindray; Chart Industries; Drägerwerk AG & Co. KGaA; DeVilbiss Healthcare |
Customization scope |
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the respiratory filters market report based on product, end-use, and region:
Product Outlook (Revenue, USD Million, 2018 - 2030)
Nebulizer Filters
Inlet Filter
Replacement Filter
Cabinet Filter
Humidifier Filters
Wick Filter
Permanent Cleanable Filter
Mineral Absorption Pads
Demineralization Cartridges
Positive Airway Pressure Device Filters
Ultra-fine Foam Inlet Filter
Polyester Non-woven Fiber Filter
Acrylic & Polypropylene Fiber Filter
Oxygen Concentrators Filters
HEPA Filter
Cabinet Filter
Pre-Inlet Filter
Inlet Filter
Micro Disk Filter
Felt Intake Filter
Bacterial Filter
Hollow-membrane Filter
Ventilator Filters
Mechanical Filters
Electrostatic Filters
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Outpatient Facilities
Home Care
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Mexico
Argentina
MEA
South Africa
Saudi Arabia
UAE
Kuwait
b. The global respiratory filters market size was estimated at USD 532.3 million in 2022 and is expected to reach USD 549.9 million in 2023.
b. The global respiratory filters market is expected to grow at a compound annual growth rate of 5.5% from 2023 to 2030 to reach 802.4 million in 2030.
b. In 2022, the PAP device filters segment accounted for the largest market share of 23.9%. Positive Airway Pressure (PAP) device filters are a critical component of PAP therapy, commonly used to treat sleep-related breathing disorders such as obstructive sleep apnea. Thus, the rising prevalence of sleep apnea across the globe is driving the market for these filters.
b. Key players within the global market for respiratory filters include Philips Healthcare, Teleflex Incorporated, Fisher & Paykel Healthcare, Ambu A/S, Precision Medical, CareFusion, Inspired Medical, Hamilton Medical AG, etc
b. Rising adoption of various respiratory devices such as PAP device, nebulizer, oxygen concentrators, etc. and technological advancement in the filters to improve the efficacy is driving the market growth.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."